Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale

@article{Rosa2018PercutaneousCV,
  title={Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale},
  author={S. De Rosa and H. Sievert and J. Sabatino and A. Polimeni and S. Sorrentino and C. Indolfi},
  journal={Annals of Internal Medicine},
  year={2018},
  volume={168},
  pages={343-350}
}
  • S. De Rosa, H. Sievert, +3 authors C. Indolfi
  • Published 2018
  • Medicine
  • Annals of Internal Medicine
  • Patent foramen ovale (PFO) is a common finding that has been reported in 10% to 35% of persons (1, 2). The presence of PFO increases the risk for cardioembolic cerebrovascular accidents, such as stroke transient ischemic attacks (TIA), but most persons with PFOs remain asymptomatic and do not develop serious complications (2). Among young persons with a cryptogenic stroke, the prevalence of PFO is high (3), and approximately half have no apparent underlying causes (4). Because PFO may be a nest… CONTINUE READING
    46 Citations
    Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale.
    Cryptogenic stroke and patent foramen ovale (abridged and translated version)
    • 3
    Patent Foramen Ovale Closure
    • 1

    References

    SHOWING 1-10 OF 46 REFERENCES
    Patent Foramen Ovale and Stroke
    • S. Homma, R. Sacco
    • Medicine
    • Current treatment options in cardiovascular medicine
    • 2003
    • 158
    • PDF
    Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
    • 773
    • PDF
    Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    • 703
    • Highly Influential
    • PDF
    Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    • 652
    • PDF
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
    • 417
    • PDF
    Is patent foramen ovale a modifiable risk factor for stroke recurrence?
    • 71
    • PDF
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
    • 431
    • Highly Influential
    • PDF
    Long‐Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
    • 413
    • Highly Influential
    • PDF